- Home
- Healthcare professionals
- ACE Horizon Scanning
- Guardant360 CDx for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Brief
Guardant360 CDx for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Condition
Cancer
16 August 2022
Published on 16 Aug 2022
Last Updated on 16 Aug 2022
This Horizon Scanning Brief provides an assessment of the Guardant360 CDx liquid biopsy test for patients with locally advanced or metastatic non-small cell lung cancer.